{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 122,
        "end": 134
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 296,
        "end": 316
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 283,
        "end": 290
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "16719540_4",
  "text": "The reasons why doses are not individualised routinely are difficulties in defining , predicting and achieving an optimal fluorouracil exposure or dose because of a narrow therapeutic index , nonlinear pharmacokinetics , variabilities in administration rates and metabolism , and in targets like thymidylate synthase ."
}
